Psilocybin Media Resources

The Psilocybin Media Landscape

The media landscape around psilocybin and psychedelic science has changed enormously since the early 2000s. Where coverage was once dominated by countercultural publications and fringe websites, the field now encompasses major scientific journals, mainstream documentary series on global streaming platforms, bestselling popular science books, and dedicated podcasting networks drawing millions of listeners.

This proliferation of media brings both opportunity and risk. High-quality science journalism and accurately reported clinical research now coexist with sensationalised anecdotes, commercial promotion dressed up as education, and in some cases, actively misleading content. Navigating this landscape requires some critical tools — which this page aims to provide alongside its specific recommendations.

The resurgence of mainstream psychedelic media coverage is generally dated to Michael Pollan's 2018 book How to Change Your Mind, which brought the clinical research context to a mass audience for the first time in decades. Since then, psilocybin has been covered in the New York Times, the Guardian, the BBC, and most major science publications, and the number of academic papers published on psychedelics has increased dramatically year-on-year.

Essential Books

How to Change Your Mind — Michael Pollan (2018)

The single most important popular book on the contemporary psychedelic research renaissance. Pollan, a science journalist best known for writing about food and farming, brings the same methodical curiosity to psychedelics — interviewing the leading researchers (Roland Griffiths at Johns Hopkins, Robin Carhart-Harris at Imperial College London, Matthew Johnson, Bill Richards, and others) and carefully undertaking his own guided experiences with LSD, psilocybin, and 5-MeO-DMT.

The book's strength is its balance: Pollan is neither a counterculture advocate nor a sceptic. He presents the clinical evidence accurately, discusses the genuine limitations of current research, and is honest about both the transformative potential and the risks of psychedelic experiences. It is the recommended first book for anyone approaching this subject from outside the psychedelic community.

Netflix adapted the book into a four-part documentary series in 2022, covering LSD, psilocybin, MDMA, and mescaline in separate episodes.

The Doors of Perception — Aldous Huxley (1954)

Not about psilocybin specifically — Huxley's account documents his experience with mescaline — but it remains essential reading for understanding the intellectual framework through which Western culture first began grappling with psychedelic experience. Huxley's proposal that the brain functions as a "reducing valve" for consciousness, and that psychedelics might temporarily lift that reduction, has proved remarkably durable as an intuition about how these substances work, even if the precise neuroscience has evolved significantly since.

The prose is extraordinary — Huxley was one of the finest writers of the twentieth century — and the book's description of the aesthetic intensification of ordinary objects (a bunch of garden flowers, a chair) under mescaline remains one of the best descriptions of the phenomenology of a moderate psychedelic experience in English literature.

Be Here Now — Ram Dass (1971)

Originally published as Remember, Be Here Now, this book chronicles Richard Alpert's (later Ram Dass) transformation from Harvard psychology professor experimenting with psilocybin alongside Timothy Leary in the early 1960s to spiritual teacher following his time with Neem Karoli Baba in India. The book is not scientific in any conventional sense, but it is a primary document of how the early psychedelic research at Harvard intersected with Eastern spiritual traditions, and its influence on the subsequent culture surrounding psychedelics is immeasurable.

Context for reading: Be Here Now reflects 1960s counterculture and its blend of psychedelic experience with Hindu spirituality. Read it as a historical and cultural document rather than a practical guide.

The Psychedelic Explorer's Guide — James Fadiman (2011)

Fadiman, who conducted some of the earliest formal research on psychedelics and creativity in the 1960s (his 1966 study on problem-solving under mescaline with Myron Stolaroff is a landmark), provides a practical, harm-reduction-oriented guide to psychedelic experiences. The book covers preparation, dose selection, the role of a sitter, working with difficult experiences, and integration. It also provides the first systematic documentation of what Fadiman later named "microdosing" protocols.

The Psychedelic Explorer's Guide is the most practically useful book for anyone considering or preparing for a psilocybin experience. Its approach is measured, evidence-conscious without being purely clinical, and genuinely oriented toward maximising safety and benefit.

LSD: My Problem Child — Albert Hofmann (1980)

The autobiography of the Swiss chemist who first synthesised LSD in 1938 and accidentally discovered its psychoactive properties in 1943. Hofmann's account of his own early experiences, the subsequent development of LSD research, and his deep ambivalence about the cultural trajectory the substance took is essential reading for understanding the history of psychedelics in the twentieth century.

Though primarily about LSD rather than psilocybin, Hofmann also isolated and named psilocybin and psilocin after analysing samples of Psilocybe mexicana provided by ethnomycologist Gordon Wasson in 1957. His account of this collaboration and of his meetings with the Mazatec curandera Maria Sabina provides vital historical context.

Sacred Knowledge — William Richards (2015)

Richards is one of the longest-serving clinical researchers in psychedelic therapy, having conducted sessions at Maryland Psychiatric Research Center in the 1970s and resumed this work at Johns Hopkins in the 2000s. Sacred Knowledge is a synthesis of his decades of clinical experience, exploring the relationship between psychedelic experiences and mystical states across religious traditions. It is more philosophical and spiritual in orientation than empirically scientific, but it represents a thoughtful attempt by a serious clinician to make sense of what he has observed in thousands of psilocybin sessions.

Additional Recommended Reading

• The Road to Eleusis — R. Gordon Wasson, Albert Hofmann, Carl A.P. Ruck (1978): The scholarly argument that the ancient Greek Eleusinian Mysteries involved an ergot-derived psychedelic drink. Foundational for understanding the deep history of psychedelic use.
• Food of the Gods — Terence McKenna (1992): McKenna's "stoned ape" hypothesis is not scientifically credible in its strongest form, but his broader argument about the historical relationship between humans and psychoactive plants is cultural reading of interest.
• The Harvard Psychedelic Club — Don Lattin (2010): A journalistic account of Timothy Leary, Richard Alpert, Huston Smith, and Andrew Weil at Harvard in the early 1960s, and how their divergent responses to psilocybin shaped their subsequent careers and the culture of the 1960s.
• Psilocybin Mushrooms of the World — Paul Stamets (1996): The standard identification guide for psilocybin-containing fungi, written by the world's best-known mycologist. Essential reference for the species section.
• Stealing Fire — Steven Kotler & Jamie Wheal (2017): Covers the broader landscape of flow states and ecstatic experiences, with a chapter on psychedelics and their relationship to other altered state induction methods.

Essential Documentaries

Fantastic Fungi (2019)

Directed by Louie Schwartzberg, this visually stunning documentary begins with the broader story of fungi — their ecological importance, their role in forest communication, their history — before moving into the story of psilocybin mushrooms specifically, featuring extended interviews with Paul Stamets and briefer appearances by Michael Pollan, Robin Carhart-Harris, and others.

Fantastic Fungi is the single best documentary introduction to both the science of fungi and the cultural and clinical story of psilocybin. It is available on Netflix and other streaming platforms. The cinematography, particularly the time-lapse sequences of mycelial growth, is remarkable.

Content note: The documentary is emotionally moving and generally accurate, though it tends toward enthusiasm over analytical balance in places. It is not a good source for the specifics of clinical protocols or risk profiles, but as a cultural and ecological overview it is excellent.

How to Change Your Mind (Netflix, 2022)

A four-part docuseries adapted from Pollan's book, with each episode dedicated to a different substance: LSD, psilocybin, MDMA, and mescaline. Pollan narrates and appears as an on-screen presence, and the series includes documentary footage of clinical sessions, interviews with leading researchers, and historical archival material.

The psilocybin episode is particularly strong, featuring footage from Johns Hopkins and interviews with Roland Griffiths, Matthew Johnson, and others directly involved in the current research renaissance. The series is more careful and evidence-conscious than most psychedelic documentaries.

From Shock to Awe (2018)

Directed by Makari Espe, this documentary follows two US military veterans with severe PTSD as they pursue healing through ayahuasca and psilocybin ceremonies in a non-clinical setting. Less scientifically rigorous than the Pollan adaptations but emotionally powerful and an important document of how psychedelic experiences can address trauma in ways that conventional treatment has not achieved. Available on various streaming platforms.

Content note: Contains descriptions of war trauma, suicidal ideation, and PTSD symptoms.

Additional Documentaries Worth Watching

• The Last Shaman (2016) — A narrative documentary about a young man with treatment-resistant depression who travels to the Amazon for ayahuasca treatment. Available on Netflix.
• Descending the Mountain (2019) — Documents participants in a psilocybin therapy programme, focusing on the integration process. Rarely seen but highly regarded by therapists in the field.
• Neurons to Nirvana (2013) — Covers five major psychedelic substances including psilocybin, with a focus on therapeutic applications. More dated now but still a solid historical overview.
• A New Understanding: The Science of Psilocybin (2015) — A focused documentary specifically on the clinical research at Johns Hopkins and New York University, featuring Roland Griffiths, Bill Richards, and terminal cancer patients receiving psilocybin for existential distress. Very moving and clinically informative.

Recommended Podcasts

The Tim Ferriss Show

Ferriss, best known for The 4-Hour Workweek, has become one of the most important popularisers of psychedelic research, largely because he has donated significant personal resources to research at Johns Hopkins and interviews the leading researchers directly. His podcast episodes with Roland Griffiths, Robin Carhart-Harris, Michael Pollan, James Fadiman, and others are among the most listened-to and substantive public conversations about psilocybin research. Available on all major podcast platforms.

Psychedelics Today

Hosted by Joe Moore and Victoria Hanna, Psychedelics Today is one of the most rigorously educational podcasts in the space. Episodes cover research, therapy training, policy, integration, harm reduction, and the history of psychedelics. Guests include researchers, therapists, policy advocates, and people with lived experience. The hosts are trained in psychedelic-assisted therapy and bring genuine professional knowledge to their interviews. Available on all major platforms.

The Third Wave Podcast

Paul Austin's podcast focuses particularly on microdosing and the professional and functional applications of psychedelics, while also covering therapeutic and spiritual dimensions. The Third Wave organisation also produces high-quality written guides and has been influential in developing accessible harm-reduction frameworks for microdosing specifically.

MAPS Podcast

The Multidisciplinary Association for Psychedelic Studies produces a podcast featuring extended conversations with researchers involved in MAPS-sponsored clinical trials. The content skews toward MDMA-assisted therapy for PTSD (MAPS's primary research focus) but covers psilocybin and the broader research landscape. Particularly valuable for understanding the regulatory and clinical development dimensions of psychedelic therapy.

Huberman Lab — Selected Episodes

Stanford neuroscientist Andrew Huberman has produced several episodes covering the neuroscience of psilocybin and related compounds. The episodes are typically long-form (two to four hours) and go into significant neurobiological detail. Available on YouTube and all major podcast platforms. The psilocybin-specific episodes have been criticised in some quarters for not adequately representing uncertainty in the research, but as an introduction to the neuroscience they are thorough.

Other Recommended Podcasts

• Being Human — Rick Hanson's podcast occasionally covers psychedelic research in the context of wellbeing and neuroscience.
• Psychedelic Therapy Frontiers — Focused on clinical training and the practice of psychedelic-assisted therapy; useful for anyone interested in the therapy context rather than just the science.
• The Synthesis Podcast — From the Synthesis Institute, covering a range of topics related to psychedelic experiences, integration, and the development of the retreat and therapy sector.

Academic Journals

For those who want to read the primary research rather than its popular interpretation, the following journals are the primary venues for peer-reviewed psilocybin and psychedelic science:

• Psychopharmacology: One of the oldest and most respected journals in the field, publishing pharmacological and clinical research on psychoactive substances including psilocybin. Many of the foundational studies from Imperial College London appeared here.
• Journal of Psychopharmacology: Similar scope to Psychopharmacology; published the important UK-based psilocybin studies including those of Nutt, Carhart-Harris, and colleagues.
• JAMA Psychiatry: Published some of the most impactful psilocybin for depression studies, including the Johns Hopkins 2020 study on treatment-resistant depression that received very wide media coverage.
• Neuropsychopharmacology: Covers the neurobiological mechanisms of psychedelics; less accessible to non-specialists but essential for the science.
• Frontiers in Psychiatry: Open-access journal that has published extensively on psychedelic-assisted therapy models and reviews. The open-access nature means all articles are freely available without subscription.
• Psychedelic Medicine: A relatively new dedicated journal specifically for psychedelic research, launched in 2023. Covers clinical, preclinical, historical, policy, and ethical dimensions.

PubMed (pubmed.ncbi.nlm.nih.gov) indexes all of the above and is the most comprehensive free database for finding primary research. Searching "psilocybin" filtered to the last five years will return a large and manageable body of recent clinical literature.

Online Resources and Databases

• MAPS Research Archive (maps.org): The Multidisciplinary Association for Psychedelic Studies maintains an extensive research archive organised by substance and condition. Summaries are written for lay audiences.
• Heffter Research Institute (heffter.org): A nonprofit that funds and supports psychedelic research; their website maintains a library of sponsored studies.
• Erowid (erowid.org): A long-established harm-reduction database covering most psychoactive substances. Includes pharmacological data, experience reports, legal information, and safety guidance. While not peer-reviewed, it is a valuable reference for pharmacological and harm-reduction information.
• PsychonautWiki (psychonautwiki.org): A community-maintained harm-reduction encyclopaedia covering pharmacology, effects, dosing, and risks of psychoactive substances. Generally accurate on pharmacological basics; treat specific dosing information as a starting point rather than a definitive guide.
• DanceSafe (dancesafe.org): Harm reduction organisation that provides drug testing kits and information; the website includes drug-specific information including psilocybin.
• Zendo Project (zendoproject.org): Psychological support service for difficult psychedelic experiences at festivals and events; the website also has excellent guidance on psychedelic crisis support and integration.
• Fireside Project (firesideproject.org): Provides a psychedelic peer support line (call or text 62-FIRESIDE) for people experiencing difficult psychedelic experiences. Also maintains resources on preparation and integration.

News Sources Covering Psychedelic Research

The quality of mainstream news coverage of psychedelic research has improved considerably since 2015 but remains variable. The following outlets tend to produce more consistently accurate coverage:

• STAT News (statnews.com): US health and science news publication that covers psychedelic research with rigour comparable to its pharmaceutical and biotech coverage. One of the best sources for updates on clinical trials and regulatory developments.
• The Guardian — Science section: Publishes regular coverage of psychedelic research, drawing on the UK research community at Imperial College London and elsewhere.
• Scientific American: Feature articles on psychedelic science appear regularly and are written to be accessible to non-specialists while maintaining scientific accuracy.
• DoubleBlind (doubleblindmag.com): Independent magazine dedicated to psychedelic coverage, combining journalism with harm reduction education. Higher quality than much of the psychedelic media space and generally careful about distinguishing evidence from advocacy.
• Psychedelic Alpha (psychedelicalpha.com): Focuses on the business and regulatory dimensions of the psychedelic sector; useful for tracking clinical trial progress and regulatory decisions.
• Lucid News (lucid.news): Covers psychedelic science and culture with a generally positive orientation; quality of individual articles varies.

How to Evaluate Media Quality

Given the volume of psychedelic media now available, the ability to evaluate quality is important. Key indicators:

Quality indicators:

• Named researchers and institutions; you can look them up independently
• Peer-reviewed sources cited, with accessible links or references
• Accurate and balanced representation of risks alongside benefits
• Acknowledgement of the limitations of current evidence
• No commercial relationships undisclosed (supplement sales, retreat promotion, etc.)
• Distinction made between clinical/supervised and unsupervised contexts

Red flags:

• Anecdotal evidence presented as clinical proof ("I was cured of depression")
• Risks dismissed entirely or minimised without evidence
• Financial products (retreats, supplements, investment opportunities) tied to content
• Guaranteed outcome claims ("psilocybin will fix your depression")
• Unnamed sources and inability to verify credentials of quoted experts
• Absence of discussion of contraindications (who should not use psilocybin)
• Historical revisionism — e.g. attributing the end of 1960s psychedelic research entirely to political suppression while ignoring genuine methodological problems in early studies

Explore the Media Section

Using This Library Effectively

Pick a format that matches your current needs. If you are just beginning to explore this subject, start with How to Change Your Mind (book or Netflix series) and the Fantastic Fungi documentary — these provide the best combination of accessibility and accuracy as an entry point. If you are preparing for a personal experience, move to James Fadiman's Psychedelic Explorer's Guide for practical guidance. If you want to go deeper into the neuroscience, the research papers section and academic journals above will point you toward the primary literature.

For ongoing updates, Psychedelics Today (podcast) and STAT News (website) provide the best combination of frequency and quality for staying current with developments in the field.

Frequently Asked Questions

What are the best documentaries about psilocybin?

Fantastic Fungi (2019) for an ecological and cultural overview; How to Change Your Mind (Netflix, 2022) for the clinical research focus; A New Understanding (2015) for the specific Johns Hopkins and NYU research on terminal cancer patients.

What books explain psilocybin science to non-scientists?

How to Change Your Mind by Michael Pollan (2018) is the best starting point. The Psychedelic Explorer's Guide by James Fadiman (2011) is the most practically useful for preparation and harm reduction. Sacred Knowledge by William Richards (2015) is best for understanding the therapeutic and spiritual dimensions from a clinical perspective.

Are there podcasts about psychedelics and psilocybin?

Psychedelics Today, The Third Wave Podcast, and The Tim Ferriss Show (selected episodes) are the most consistently high quality. The MAPS Podcast covers clinical trial developments in detail.

What academic journals publish psilocybin research?

Psychopharmacology, Journal of Psychopharmacology, JAMA Psychiatry, Neuropsychopharmacology, and Frontiers in Psychiatry. Use PubMed to search across all of these for free.

How do I evaluate the quality of psychedelic media?

Look for named researchers and cited peer-reviewed sources; accurate representation of risks; no undisclosed commercial relationships; and acknowledgement of evidence limitations. Red flags: guaranteed outcome claims, anecdote presented as proof, risks dismissed entirely, and commercial products tied to content.

Are there online databases of psilocybin research?

PubMed (pubmed.ncbi.nlm.nih.gov) is the most comprehensive free database. MAPS maintains a curated research archive at maps.org. Erowid and PsychonautWiki provide harm-reduction oriented pharmacological information.

What is How to Change Your Mind about?

Journalist Michael Pollan's 2018 investigation into the history and contemporary science of psychedelics, featuring interviews with leading researchers and Pollan's own carefully considered personal experiences. It is widely credited with bringing mainstream attention to the current clinical research renaissance.